BSECompany Update15 Oct 2026 · 15 Oct 2026, 06:04 pm
We wish to inform to the Exchange that TRIDENT MEDIQUIP LIMITED (TML) (CIN: U33309GJ2019PLC110421), a subsidiary company has made Private Placement of equity shares to other shareholders. Pursuant to the above allotment to other shareholders, the shareholding of Trident Lifeline Limited in Trident Mediquip Limited stands at 58.23%.
Trident Lifeline Ltd · 543616
✦ AI SummaryRelated Party
Trident Lifeline Ltd has informed the exchange that its subsidiary, Trident Mediquip Limited, has made a private placement of equity shares to other shareholders, resulting in Trident Lifeline's shareholding in Trident Mediquip standing at 58.23%.
Analysis Scores
Earnings Impact2/10
Growth Catalyst3/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Trident Lifeline Ltd - 543616 - Announcement under Regulation 30 (LODR)-Acquisition
Attachments (1)
📄pdf
Download →
696c224f-4d35-45d4-90e3-bae8e1af2867.pdf
View document text
Date: 15.10.2026
BSE Limited Stock ID: TLL
P. J. Towers, Scrip Code: 543616
Dalal Street, Fort, ISIN: INE0MKA01014
Mumbai – 400001.
Dear Sir/Ma’am,
Sub: Regulation 30 of the Securities and Exchange Board of India (Listing Obligations
and Disclosure Requirements) Regulations, 2015
Dear Sir/Ma’am,
We wish to inform to the Exchange that TRIDENT MEDIQUIP LIMITED (TML) (CIN:
U33309GJ2019PLC110421), a subsidiary company has made Private Placement of equity
shares to other shareholders. Pursuant to the above allotment to other shareholders, the
shareholding of Trident Lifeline Limited in Trident Mediquip Limited stands at 58.23%.
We enclosed herewith the details required under Regulation 30 of SEBI (LODR) Regulations,
2015 and SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated
January 30, 2026 as Annexure – A.
Thanking You.
Yours faithfully,
FOR TRIDENT LIFELINE LIMITED
NIKITA SHARMA
COMPANY SECRETARY AND COMPLIANCE OFFICER
M. NO.: A60595
Registered Office: 2004, 2nd Floor, North Extension, Falsawadi, Ring Road, Surat-395003, Gujarat, INDIA.
Tel : +91 261 2451274, 2451284 Email : info@tridentlifeline.com Web : www.tridentlifeline.com
Factory Address: Plot No. 4240, Road No. 42, Sachin GIDC, Surat, Gujarat - 394230, India.
Annexure‐A
Information under Regulation 30 of SEBI (LODR) Regulations, 2015 and SEBI Master Circular No.
HO/49/14/14(7)2025‐CFD‐POD2/I/3762/2026 dated January 30, 2026
Sr. Particulars Details
1 Name of the target entity, TRIDENT MEDIQUIP LIMITED (CIN:
details in brief such as size, U33309GJ2019PLC110421) Company incorporated
turnover etc. under the provisions of the Companies Act, 2013,
having its Registered Office in Surat, Gujarat
Capital Details:
Authorized Share Capital: Rs. 11,00,00,000/-
divided into 1,10,00,000 Equity Shares of Rs.10/-
each
Paid‐up Share Capital: Rs. 10,24,69,800/- divided
into 1,02,46,980 Equity Shares of Rs.10/- each
Turnover: 27.31 Cr
2 Whether the acquisition would Yes, TRIDENT MEDIQUIP LIMITED, Subsidiary of
fall within related party Trident Lifeline Limited, therefore is a related
transaction(s) and whether the party. Also Mr. Amit Bhupendra Halvawala and Mr.
promoter/ promoter group/ Chetan Chandrakant Jariwala (director’s Relative of
group companies have any Rupaben Jariwala) are member cum Director, Mr.
interest in the entity being Hardik Jigishkumar Desai members and all of above
acquired? If yes, nature of are part of promoters/promoter group/board of
interest and details thereof and acquiring Company i.e being Trident Lifeline
whether the same is done at Limited (The Company), have an interest in the
“arm’s length” entity being acquired (TML).
The transaction is being undertaken on an arm's
length basis.
3 Industry to which the entity Medical Device Industry
being acquired belongs
4 Objects and impact of TRIDENT MEDIQUIP LIMITED is a subsidiary of the
acquisition (including but not company. In order to further allotment of shares to
limited to, disclosure of reasons other shareholders, percentage of holding its stake
for acquisition of target entity, if in TML stands at 58.23%.
its business is outside the main
line of business of the listed
entity)
Registered Office: 2004, 2nd Floor, North Extension, Falsawadi, Ring Road, Surat-395003, Gujarat, INDIA.
Tel : +91 261 2451274, 2451284 Email : info@tridentlifeline.com Web : www.tridentlifeline.com
Factory Address: Plot No. 4240, Road No. 42, Sachin GIDC, Surat, Gujarat - 394230, India.
5 Brief details of any NA
governmental or regulatory
approvals required for the
acquisition.
6 Indicative time period for NA
completion of the acquisition
7 Consideration - whether cash NA
consideration or share swap
and details of the same;
8 Cost of acquisition or the price NA
at which the shares are
acquired;
9 Percentage of shareholding / Pre holding: 59.67%
control acquired and / or
number of shares acquired; Post holding: 58.23%
10 Brief background about the Date of incorporation: October 19, 2019
entity acquired in terms of
products/line of business Product/line of business: Medical Device Industry
acquired, date of incorporation,
history of last 3 years turnover, Last 3 years' turnover:
country in which the acquired Financial year 2023-24- 20.58 Cr.
entity has presence and any Financial Year 2024-25- 21.29 Cr.
other significant information (in Financial Yeat 2025-26- 27.31 Cr.
brief);
Presence of entity: India
Registered Office: 2004, 2nd Floor, North Extension, Falsawadi, Ring Road, Surat-395003, Gujarat, INDIA.
Tel : +91 261 2451274, 2451284 Email : info@tridentlifeline.com Web : www.tridentlifeline.com
Factory Address: Plot No. 4240, Road No. 42, Sachin GIDC, Surat, Gujarat - 394230, India.